| Memorializing Martin Y. Iguchi |
|
Quarterly Insights from the RAND Drug Policy Research Center
|
|
Quarterly insights from the RAND Drug Policy Research Center |
May 2023
|
|
|
|
|
|
This article memorializes Martin Y. Iguchi (1955-2021), former co-Director of the RAND DPRC, a pioneering clinical scientist, lifelong champion of equity and racial justice, and valued mentor to many of today's DPRC affiliates (including the current co-Directors). Read more »
|
|
|
|
Photo by RAND Europe |
There’s still time to sign up for the sixteenth annual meeting of the International Society for the Study of Drug Policy (ISSDP) in Leuven, Belgium, from 30 May – 01 June 2023, at KU Leuven University. Please join us!
Read more »
|
|
|
|
|
Photo by Chinnapong/Adobe Stock |
Despite increases in the number of substance use disorder treatment facilities in rural areas, there has been less growth in nearby facilities offering evidence-based medication treatment for opioid use disorder.
Read more »
|
|
|
|
|
Photo by Heather Heiney/U.S. Air Force |
RAND researchers examined changes in behavioral health care delivered to service members with PTSD, depression, or substance use disorder by the U.S. Military Health System following the onset of the COVID-19 pandemic, including patterns of care, use of telehealth, and quality of care.
Read More »
|
|
|
|
|
The RAND Corporation is a nonprofit institution that helps improve policy and decisionmaking through research and analysis.
|
|
|
|
Privacy statement
|
|
RAND Corporation. 1776 Main Street, Santa Monica, CA 90401-3208. RAND® is a registered trademark.
|
|
|
|
|